January 30, 2026

Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising 105.91% Upside in the Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX) stands out as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $651.12 million, the company..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Strong Revenue Growth and Attractive Valuation with 17.24% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector with its focus on developing and commercializing innovative pain management solutions. Based in Stoughton, Massachusetts, this specialty pharmaceutical company..

Immunome, Inc. (IMNM) Stock Analysis: Unveiling a 37.61% Upside Potential in Promising Cancer Therapies

Investors with an eye on the biotechnology sector have plenty to consider with Immunome, Inc. (NASDAQ: IMNM). This clinical-stage biotech company is making significant strides in the development of targeted..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 348% Upside in the Biotech Sector

For investors seeking opportunities in the dynamic biotech industry, Anavex Life Sciences Corp. (NASDAQ: AVXL) presents an intriguing prospect. With a market capitalization of $438.7 million, Anavex is a biopharmaceutical..

RxSight, Inc. (RXST) Stock Analysis: A 17.85% Potential Upside in the Healthcare Sector

RxSight, Inc. (RXST), a pioneering firm in the medical devices industry, is captivating investor attention with its innovative solutions in cataract surgery. Headquartered in Aliso Viejo, California, RxSight’s prime offering..

Pharvaris N.V. (PHVS) Stock Analysis: A Biotechnology Gem with 69% Upside Potential

Pharvaris N.V. (PHVS), a promising player in the biotechnology sector, has been capturing the attention of investors with its innovative approach to tackling rare diseases. Based in Zug, Switzerland, Pharvaris..

Taysha Gene Therapies (TSHA) Stock Analysis: A 140% Upside Beckons Investors Amidst Promising Gene Therapy Advances

Taysha Gene Therapies, Inc. (TSHA) is drawing attention from the investment community with its compelling potential upside of 140.70%. As a clinical-stage biotechnology firm, Taysha is pioneering transformative adeno-associated virus-based..

AnaptysBio, Inc. (ANAB) Stock Analysis: Unveiling a 41.94% Potential Upside with Robust Buy Ratings

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology firm rooted in the heart of San Diego, California, is turning heads in the healthcare sector. With a market capitalization of $1.34 billion,..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a Remarkable 229.75% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC) stands at the forefront of innovation in the biotechnology sector, captivating investor interest with its unique approach to tackling diseases underserved by existing therapeutics. Headquartered..

Embecta Corp. (EMBC) Stock Analysis: A 61.81% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC) is drawing attention in the healthcare sector with its impressive 61.81% potential upside, making it a notable consideration for investors seeking opportunities in medical instruments and..

AMN Healthcare Services Inc (AMN): Investor Outlook on Stock Performance and Strategic Positioning

AMN Healthcare Services Inc (NYSE: AMN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of approximately $775.57 million, AMN..

GH Research PLC (GHRS) Stock Analysis: A Biotech Gem with Over 100% Upside Potential

As the biopharmaceutical industry continues to evolve, investors are keenly eyeing companies at the forefront of innovative treatments. GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin,..

iRadimed Corporation (IRMD) Stock Analysis: Evaluating the Growth Potential in MRI-Compatible Medical Devices

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in creating innovative medical devices compatible with magnetic resonance imaging (MRI). With a market cap of $1.26 billion,..

Firering targets production uplift at Zambian lime project

AIM-listed Firering moves into production expansion at its Zambian lime plant, strengthening its industrial minerals footprint...

STAAR Surgical Company (STAA) Stock Analysis: Insights into the 23.34% Potential Upside

STAAR Surgical Company (NASDAQ: STAA) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $934.99 million, STAAR Surgical..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with 63.59% Potential Upside

Investors eyeing the biotechnology sector may want to pay close attention to Oculis Holding AG (OCS), a Swiss company making significant strides in ophthalmic disease treatments. With a market capitalization..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 90.91% Potential Upside Sparks Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a biotechnology company based in New York and focused on innovative cancer therapies, is drawing significant attention from the investor community. With a robust market..

Day One Biopharmaceuticals (DAWN) Investor Outlook: Unveiling a Potential 111% Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector with its innovative approach to treating both childhood and adult diseases. As a commercial-stage company, Day One..

Nutex Health Inc. (NUTX) Stock Analysis: An Astonishing 68% Potential Upside Awaits Investors

Nutex Health Inc. (NUTX) is making waves in the healthcare sector with a remarkable potential upside of 68.32%, according to analyst target prices. With a current market cap of $1.05..

Immatics N.V. (IMTX) Stock Analysis: Exploring the 103.89% Potential Upside in the Biotechnology Sector

Immatics N.V. (NASDAQ: IMTX), a trailblazer in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment and a significant potential upside. As a..

Search

Funds

January 30, 2026

Firering targets production uplift at Zambian lime project

AIM-listed Firering moves into production expansion at its Zambian lime plant, strengthening its industrial minerals footprint...
Search

Funds

January 30, 2026

FTSE 100

Funds